Role of interleukin-17 in the pathogenesis of vitiligo

Clinical and Experimental Dermatology

Volumn 36, Issue 3, 2011, Pages 292-297

  Bassiouny, D A ^a   Shaker, O ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

ADULT; AGE; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SKIN; TISSUE LEVEL; VITILIGO;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; SKIN; VITILIGO; YOUNG ADULT;

EID: 79952782381     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03972.x     Document Type: Article

References (23)

1. Ortonne JP, Rapini RP, Horn TD et al., eds. Dermatology. Edinburgh: Mosby, 2003: 947-73.
2. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 and regulatory T cells in human organ transplantation and autoimmune diseases. Clin Exp Immunol 2007; 148: 32-46.
3. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th 17 perspective. Autoimmun Rev 2007; 6: 169-75.
4. Weaver CT, Harrington LE, Mangan PR et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-88.
5. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an etiological factor in vitiligo. J Europ Acad Derm Venereol 2007; 21: 865-76.
6. Namian AM, Shahbaz S, Samanpoor R et al. Association of interferon-gamma and tumor necrosis factor-alpha polymorphism with susceptibility to vitiligo in Iranian patients. Arch Dermatol Res 2008; 301: 21-5.
7. Alkhateeb A, Fain PR, Thody A et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives. Pigment Cell Res 2003; 16: 208-14.
8. Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross reactive autoantibodies to tyrosinase and tyrosinase-related protein-2. Clin Exp Immunol 1997; 109: 495-500.
9. Wankowicz KA, van den Wijngaard RM, Tigges BJ et al. Immunopolarization of CD4C and CD8C T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-95.
10. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-74.
11. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-40.
12. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-76.
13. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. Signals mediated by transforming growth factor beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 2006; 7: 1151-6.
14. Sutton C, Brereton C, Keogh B et al. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006; 203: 1685-91.
15. Kotake S, Udagawa N, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103: 1345-52.
16. Jandus C, Bioley G, Rivals JP et al. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rhuem 2008; 58: 2307-17.
17. Basak PY, Adiloglu AK, Ceyhan AM et al. The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol 2009; 60: 256-60.
18. Moretti S, Spallanzani A, Amato L et al. New insights into the pathogenesis of vitiligo; imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002; 15: 87-92.
19. Feldmann M, Brennan FM, Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 1998; 17: 217-28.
20. Swope VB, Abdel-Malek Z, Kassem LM, Nordlund JJ. Interleukis 1 alpha and 6 and TNFα are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991; 96: 180-5.
21. Tu CX, Gu JS, Lin XR. Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci 2003; 31: 73-8.
22. Pichler R, Sfetsos K, Badics B et al. Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio. Wien Med Wochenschr 2009; 159: 337-41.
23. Mussette P, Bachelez H, Flageul B et al. Immune mediated destruction of melanocytes in halo nevus is associated with the local expansion of a limited number of T-cell clones. J Immunol 1999; 162: 1789-94.